Αποτελέσματα Αναζήτησης
CDC recommends a single dose of RSV vaccine for older adults to help prevent serious RSV infection and hospitalization. RSV vaccination is recommended for the following adults: All adults ages 75 and older. Adults ages 60–74 at increased risk of severe RSV disease.
12 Οκτ 2023 · For now, only one dose of the RSV vaccine is recommended. So far, RSV vaccines appear to provide some protection for at least two RSV seasons. Additional evaluation is planned to assess how long the protection lasts and whether additional doses will be needed.
19 Σεπ 2024 · The updated Respiratory Virus Guidance recommends that people stay home and away from others until at least 24 hours after both their symptoms are getting better overall, and they have not had a fever (and are not using fever-reducing medication).
19 Σεπ 2023 · For most healthy adults, RSV feels like a common cold. Symptoms like runny nose, cough, low fever, sneezing and sore throat can be annoying to deal with. But they’re typically mild and only last a week or two. Most people are able to manage mild RSV symptoms at home with rest, fluids and acetaminophen (Tylenol, others).
13 Σεπ 2024 · RSV feels like a cold for most people and lasts 1 to 2 weeks. For some people, RSV does more harm. RSV can lead to lower respiratory tract disease. That can cause pneumonia (lung infection) or bronchiolitis (swelling of small airways of the lungs). Lower respiratory tract disease caused by RSV is more dangerous for infants and older adults.
4 Ιαν 2024 · When should I expect a fever to appear after vaccination? Most fevers occur within a week of vaccination; however, because vaccines cause immunity in different ways, depending on how they are made, there is some variation regarding exactly when fevers following vaccination are most likely to occur.
30 Αυγ 2024 · What to know. To prevent severe RSV disease in infants, either maternal RSV vaccination or infant immunization with the RSV monoclonal antibody (nirsevimab) is recommended. Most infants will not need both. Administration of nirsevimab is recommended during October through March in most of the U.S.
